bovin
coronaviru
bcv
caus
neonat
calf
diarrhea
cd
associ
winter
dysenteri
wd
adult
dairi
cattl
also
isol
respiratori
tract
cattl
enter
feedlot
monoclon
antibodi
mab
specif
hemagglutinin
esteras
spike
surfac
protein
bovin
enter
coronaviru
becv
strain
two
bovin
respiratori
coronaviru
brcv
strain
test
becv
strain
recent
isol
brcv
strain
order
character
antigen
bcv
strain
vari
tissu
tropism
mab
high
immunofluoresc
titer
becv
brcv
strain
indic
conserv
crossreact
epitop
hemagglutin
inhibit
hi
test
smab
broadli
reactiv
hemab
brcv
cd
mab
broadli
reactiv
hi
wd
mab
bovin
coronaviru
bcv
caus
calf
diarrhea
cd
associ
winter
dysenteri
wd
adult
dairi
cattl
may
contribut
respiratori
diseas
feedlot
cattl
sever
studi
antigen
becv
isol
use
polyclon
monoclon
antibodi
studi
brcv
isol
use
mab
although
biolog
antigen
differ
becv
strain
detect
unclear
differ
distinct
becv
cd
wd
brcv
strain
differ
use
differenti
identifi
sourc
individu
strain
investig
mab
brcv
strain
mab
cd
strain
mab
wd
strain
dba
test
hi
vn
determin
antigen
related
becv
brcv
strain
becv
strain
tabl
plaqu
isol
clone
limit
dilut
describ
previous
respiratori
strain
tabl
isol
cell
cattl
ohio
feedlot
clone
limit
dilut
monoclon
antibodi
cd
strain
wd
strain
dba
brcv
strain
produc
describ
previous
briefli
femal
balbc
mice
given
intraperiton
ip
inject
ml
inactiv
purifi
bcv
strain
proteinmous
mice
titer
bcv
rang
hi
titer
use
mab
product
hybridoma
supernat
screen
fluoresc
focu
neutralizaiton
ffn
hi
test
homolog
viru
strain
ffn
test
perform
use
cell
cultur
grown
well
micropl
describ
previous
cd
wd
brcv
hybridoma
posit
ffn
hi
antibodi
bcv
use
produc
ascit
inject
clone
time
hybridoma
cell
pristaneprim
mice
mice
inject
ml
hybridoma
cell
cellsml
day
later
ascit
collect
isotyp
subisotyp
mab
determin
immunodiffus
assay
hybridoma
supernat
fluid
monospecif
antimous
immunoglobulin
sera
icn
biomed
aurora
oh
summar
tabl
hemagglutin
inhibit
hi
test
perform
use
ubottom
plate
monoclon
antibodi
brcv
becv
serial
dilut
veron
buffer
salin
vb
mix
volum
ha
unit
purifi
bcv
incub
c
h
incub
mous
erythrocyt
suspens
ad
incub
h
c
hi
titer
express
reciproc
highest
dilut
mab
complet
inhibit
ha
pellet
format
hi
titer
indic
plu
tabl
lack
hi
titer
indic
dash
two
cd
strain
becv
includ
mebu
vaccin
strain
fail
react
mab
test
hi
tabl
third
cd
strain
broadli
reactiv
becv
strain
test
hemagglutin
inhibit
mab
test
among
wd
strain
strain
react
one
classif
mab
cd
wd
brcv
among
dba
mab
direct
protein
reactiv
either
mab
direct
protein
brcv
strain
share
similar
hi
pattern
test
mab
brcv
strain
react
similarli
mab
differ
test
brcv
mab
mab
enter
respiratori
strain
fail
inhibit
hemagglutin
caus
brcv
strain
hi
result
show
dba
mab
smab
broadli
reactiv
hi
hemab
tabl
protein
effici
protein
hemagglutin
follow
smab
would
effici
inhibit
hemagglutinaiton
hemab
brcv
cd
mab
broadli
reactiv
hi
wd
mab
cpe
reduct
viru
neutral
vn
test
perform
use
cell
cultur
grown
micropl
describ
previous
briefli
serial
dilut
mab
mix
volum
viru
suspens
contain
tcid
ml
incub
c
min
four
well
cell
inocul
ml
virusserum
mixtur
incub
day
c
neutral
antibodi
titer
mab
express
reciproc
highest
dilut
inhibit
cpe
vn
titer
indic
plu
tabl
lack
vn
titer
indic
dash
mab
test
broadli
reactiv
vn
test
tabl
hi
test
tabl
wherea
mebu
vaccin
sdc
calf
diarrhea
strain
fail
react
mab
hi
test
neutral
mab
direct
cd
brcv
strain
addit
mebu
cd
strain
also
neutral
mab
direct
dba
wd
becv
strain
vn
reactiv
pattern
mebu
cd
strain
dba
wd
strain
ident
one
anoth
cd
strain
similar
pattern
vari
regard
lack
neutralizaiton
mab
brcv
mab
test
vn
success
neutral
bcv
strain
enter
respiratori
five
brcv
strain
neutral
mab
direct
cd
strain
cd
strain
neutral
brcv
mab
brcv
strain
uniqu
hi
test
fail
react
cd
wd
mab
base
hi
vn
test
mab
found
antigen
biolog
variat
exist
among
bcv
strain
variat
alway
relat
clinic
sourc
isol
agreement
previou
studi
use
polyclon
antisera
becv
isol
tsunemitsu
et
al
test
bcv
strain
isol
nasal
swab
fece
calv
found
indistinguish
test
iem
ha
vn
use
hyperimmun
serum
tsunemitsu
et
al
determin
hi
vn
titer
polyclon
antibodi
variou
becv
strain
found
reactiv
pattern
strain
could
group
accord
clinic
origin
cd
wd
use
isol
test
mab
produc
studi
rather
polyclon
hyperimmun
antiserum
similar
hi
pattern
found
could
predict
base
clinic
origin
reynold
et
al
found
hyperimmun
antiserum
three
differ
bcv
isol
respiratori
enter
show
vn
homolog
heterolog
isol
signific
crossreact
eight
isol
intestin
respiratori
origin
use
polyclon
antiserum
mab
direct
protein
mebu
cd
strain
michaud
dea
found
wd
isol
quebec
close
relat
use
polyclon
antibodi
could
classifi
distinct
antigen
subgroup
base
reactiv
smab
mebu
strain
vn
hi
test
find
agreement
result
present
previou
studi
becv
isol
close
relat
use
polyclon
antiserum
could
classifi
antigen
subgroup
base
vn
hi
test
result
mab
milan
et
al
indic
variat
unrel
clinic
sourc
affect
antigen
determin
protein
occur
among
becv
strain
isol
quebec
strain
group
differ
mab
hi
titer
prototyp
mebu
strain
similarli
present
studi
ha
activ
mebu
strain
inhibit
mab
test
brcv
isol
uniqu
among
respiratori
isol
test
becv
mab
find
consist
hi
vn
test
test
mab
hyperimmun
sera
howev
use
brcvmab
strain
antigen
relat
brcv
strain
test
hi
vn
differ
vn
hi
test
result
expect
correl
activ
dispar
vn
hi
result
report
mab
protein
quebec
bcv
isol
mab
protein
mebu
strain
mab
protein
wd
strain
moreov
mab
reactiv
separ
epitop
bcv
protein
protein
contain
three
antigen
region
b
c
domain
subdivid
two
epitop
react
neutral
antibodi
protein
three
antigen
region
two
b
b
c
react
neutral
antibodi
present
studi
mab
react
hemagglutin
epitop
third
mab
data
shown
react
nonhemagglutin
epitop
although
epitop
separ
involv
vn
activ
also
true
mab
demonstr
vn
activ
strain
fail
inhibit
hemagglutin
find
agreement
et
al
mab
protein
neutral
one
hi
activ
addit
mab
inhibit
ha
activ
neutral
activ
agreement
michaud
dea
report
hemab
mebu
strain
hi
activ
neutral
activ
result
studi
indic
antigen
biolog
variat
detect
mab
exist
among
bcv
isol
variabl
alway
relat
clinic
sourc
isol
one
brcv
strain
extent
mebu
vaccin
strain
repres
uniqu
bcv
isol
distinct
enter
respiratori
strain
base
least
oneway
hi
vn
reactiv
pattern
use
mab
